Log in

Start Your Membership Now

U.S. Department of Health and Human Services, U.S. Food and Drug Administration announces the availability of funding for implementation of the Drug Development Tools Research Grants (U01) Clinical Trial Optional. The purpose of this grant is to support research to continue the development of drug development tools that have an accepted Letter of Intent within a drug development tool qualification program within either the Center for Biologics Evaluation and Research or the Center for Drug Evaluation and Research.

Contractors should refer to Section VII, Agency Contacts, in the RFP for information regarding each organization's grants management contact . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Federal Government